UNH has recently exhibited an uptrend, breaking above the 338.45 resistance level after multiple prior rejections. This upward movement is supported by an ascending trendline established over the past three weeks. Historically, the stock experienced a significant sell-off earlier in the year, dropping approximately 60% over four months to a low of 231.57. Subsequently, it formed a higher low at 295.43, signaling renewed buying interest. On the daily chart, UNH reached a double top at 378.46 before its decline. Having now surpassed the 338.45 level, the stock is poised for a retest of the 356.65 resistance, with a subsequent target at the 375.12 zone, which represents a prior gap-down level. The broader healthcare sector's positive momentum, influenced by congressional discussions on ACA subsidy support, is contributing to UNH's strength. Upcoming earnings, anticipated around January 27th next year, are identified as a critical determinant for the stock's future trajectory. The analysis forecasts UNH to reach 375.12 by the end of the current month, contingent on sustained sector performance and an overall market rally. An hourly chart confirms an ascending price channel, with buyers maintaining higher lows and sellers demonstrating limited control. Increased volatility and consolidation above the 344.98 high suggest continued upward potential. A crucial failure bound for this bullish scenario is established at the 317.31 support level.